Since January 2020, she serves as the director of the research Institut Necker-Enfants Malades (INEM) in Paris.
[2][3] She then trained as a pediatrician in the team of Professor Fabio Sereni in Milan specializing in pediatric nephrology.
From 2003 on, she began to build up her own laboratory ("Mechanisms and Therapeutic Strategies of Chronic Kidney Disease"), which she has headed since then.
[10][11][12] In particular, her team revealed a detrimental role of the epidermal growth factor receptor (EGFR) pathway in the fate of CKD, the activation of which aggravates renal lesions after nephron reduction.
[13][14] Beyond that, she has been involved in several translational studies that have succeeded in the identification of novel biomarkers (of the progression) of renal diseases in humans.